Submit your Product Liability claim details for a free, no obligation case review.
Get Started:
product_liability birth-control-patchPotentially fatal Ortho Evra risk factors have generated serious controversy since the publication of reports linking 23 deaths to this birth control patch. Ortho Evra is the first birth control patch approved by the FDA as a safe and effective method of reproductive control. The Ortho Evra risk factors were reportedly not known to the drug''s maker, Ortho McNeil, or the FDA when the birth control patch was approved in November 2001.
Fatal blood clots are the most serious Ortho Evra risk discovered since the drug''s introduction to the market. Of the 23 deaths linked to Ortho Evra risk factors, 17 have been caused by serious blood clots. A lawsuit was filed in July 2005 against Ortho McNeil on behalf of a 30-year-old woman who suffered fatal blood clots thought to be linked to the Ortho Evra risk. The woman was admitted into the intensive care unit shortly before her death suffering from severe headache, visual problems, vomiting, and nausea.
The other deaths reported in connection with Ortho Evra risk factors were the result of heart attacks and strokes. One of the most recent deaths linked to Ortho Evra was suffered by a 25 year old woman who suffered fatal headaches thought to be linked to a surge of hormone release from the birth control patch. The youngest woman to die, as reported in a recent study, was an 18 year old college student who collapsed in the New York subway.
Ortho McNeil and other medical experts refute the allegations that these deaths were the result of Ortho Evra risk factors. The pharmaceutical company has been investigating the reported deaths and has not found any causal factor linking these deaths to Ortho Evra. The company also points out that not a single fatal adverse side effect has been reported in the clinical trials conducted to assess Ortho Evra risk factors.
A 2005 press release claims that Ortho Evra risks are three times greater than those associated with birth control pills. This press release was based on independent conclusions drawn from FDA data. The drug''s maker and other experts have indicated that these findings actually allege that the Ortho Evra risk is that three women for every 200,000 will suffer a serious adverse reaction related to the birth control patch. This Ortho Evra risk is still many times lower than the risk of complications for women who are pregnant past the 20th week.
The product information already included with birth control patch packaging describes other known Ortho Evra risk warnings. Women who smoke or have a history of certain medical conditions are advised that using the birth control patch may bring added Ortho Evra risk. Women who had or have had a heart attack, stroke, clotting disorders, high blood pressure, diabetes, high cholesterol, chest pain, and other medical conditions may be at an increased risk of serious side effects when using Ortho Evra birth control patches.
Have you been injured by the Ortho Evra Patch?
Lawsuits have already been filed on behalf of women who have suffered a fatal blood clot from the Ortho Evra birth control patch. Please contact an experienced Ortho Evra birth control patch attorney to learn more about your legal rights.
The maker of the Ortho Evra birth control patch is seeking legal protection from lawsuits over injuries caused by the product with argument...
The Food and Drug Administration approved a labeling change for the Ortho Evra birth control patch based on a new study linking the contraceptive to a greater risk of potentially fatal blood clots than the pill.
In recent years drug patches have been used and questioned by patients and doctors worldwide.
In 2005, an Army Master Sgt. died in his sleep due to a drug overdose the night that he was given a painkiller patch after his respiratory surgery. <...